Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2002 Jul;61(7):577–579. doi: 10.1136/ard.61.7.577

Anti-interleukin 1α autoantibodies

P Miossec 1
PMCID: PMC1754161  PMID: 12079894

Full Text

The Full Text of this article is available as a PDF (69.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bendtzen K., Hansen M. B., Ross C., Svenson M. High-avidity autoantibodies to cytokines. Immunol Today. 1998 May;19(5):209–211. doi: 10.1016/s0167-5699(98)01252-3. [DOI] [PubMed] [Google Scholar]
  2. Buchs N., di Giovine F. S., Silvestri T., Vannier E., Duff G. W., Miossec P. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun. 2001 Jun;2(4):222–228. doi: 10.1038/sj.gene.6363766. [DOI] [PubMed] [Google Scholar]
  3. Chabaud M., Miossec P. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model. Arthritis Rheum. 2001 Jun;44(6):1293–1303. doi: 10.1002/1529-0131(200106)44:6<1293::AID-ART221>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  4. Deleuran B. W., Chu C. Q., Field M., Brennan F. M., Katsikis P., Feldmann M., Maini R. N. Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol. 1992 Dec;31(12):801–809. doi: 10.1093/rheumatology/31.12.801. [DOI] [PubMed] [Google Scholar]
  5. Dinarello C. A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol. 1998;16(5-6):457–499. doi: 10.3109/08830189809043005. [DOI] [PubMed] [Google Scholar]
  6. Gabay C., Smith M. F., Eidlen D., Arend W. P. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J Clin Invest. 1997 Jun 15;99(12):2930–2940. doi: 10.1172/JCI119488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gallay P., Mach J. P., Carrel S. Characterization and detection of naturally occurring antibodies against IL-1 alpha and IL-1 beta in normal human plasma. Eur Cytokine Netw. 1991 Nov-Dec;2(5):329–338. [PubMed] [Google Scholar]
  8. Garrone P., Djossou O., Fossiez F., Reyes J., Ait-Yahia S., Maat C., Ho S., Hauser T., Dayer J. M., Greffe J. Generation and characterization of a human monoclonal autoantibody that acts as a high affinity interleukin-1 alpha specific inhibitor. Mol Immunol. 1996 May-Jun;33(7-8):649–658. doi: 10.1016/0161-5890(96)00017-x. [DOI] [PubMed] [Google Scholar]
  9. Graudal N. A., Svenson M., Tarp U., Garred P., Jurik A-G, Bendtzen K. Autoantibodies against interleukin 1alpha in rheumatoid arthritis: association with long term radiographic outcome. Ann Rheum Dis. 2002 Jul;61(7):598–602. doi: 10.1136/ard.61.7.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hansen M. B., Svenson M., Abell K., Varming K., Nielsen H. P., Bertelsen A., Bendtzen K. Sex- and age-dependency of IgG auto-antibodies against IL-1 alpha in healthy humans. Eur J Clin Invest. 1994 Mar;24(3):212–218. doi: 10.1111/j.1365-2362.1994.tb00991.x. [DOI] [PubMed] [Google Scholar]
  11. Hansen M. B., Svenson M., Bendtzen K. Human anti-interleukin 1 alpha antibodies. Immunol Lett. 1991 Sep;30(1):133–139. doi: 10.1016/0165-2478(91)90102-g. [DOI] [PubMed] [Google Scholar]
  12. Joosten L. A., Helsen M. M., Saxne T., van De Loo F. A., Heinegard D., van Den Berg W. B. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol. 1999 Nov 1;163(9):5049–5055. [PubMed] [Google Scholar]
  13. Jouvenne P., Fossiez F., Banchereau J., Miossec P. High levels of neutralizing autoantibodies against IL-1 alpha are associated with a better prognosis in chronic polyarthritis: a follow-up study. Scand J Immunol. 1997 Oct;46(4):413–418. doi: 10.1046/j.1365-3083.1997.d01-139.x. [DOI] [PubMed] [Google Scholar]
  14. Jouvenne P., Fossiez F., Garrone P., Djossou O., Banchereau J., Miossec P. Increased incidence of neutralizing autoantibodies against interleukin-1 alpha (IL-1 alpha) in nondestructive chronic polyarthritis. J Clin Immunol. 1996 Sep;16(5):283–290. doi: 10.1007/BF01541394. [DOI] [PubMed] [Google Scholar]
  15. Jouvenne P., Vannier E., Dinarello C. A., Miossec P. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction. Arthritis Rheum. 1998 Jun;41(6):1083–1089. doi: 10.1002/1529-0131(199806)41:6<1083::AID-ART15>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  16. Mae N., Liberato D. J., Chizzonite R., Satoh H. Identification of high-affinity anti-IL-1 alpha autoantibodies in normal human serum as an interfering substance in a sensitive enzyme-linked immunosorbent assay for IL-1 alpha. Lymphokine Cytokine Res. 1991 Apr;10(1-2):61–68. [PubMed] [Google Scholar]
  17. Ohmoto Y., Ogushi F., Muraguchi M., Yamakawa M., Sone S. Age-related increase of autoantibodies to interleukin 1 alpha in healthy Japanese blood donors. J Med Invest. 1997 Aug;44(1-2):89–94. [PubMed] [Google Scholar]
  18. Okitsu-Negishi S., Furusawa S., Kawa Y., Hashira S., Ito S., Hiruma F., Mizoguchi M., Yoshino K., Abe T. Suppressive effect of intravenous immunoglobulins on the activity of interleukin-1. Immunol Res. 1994;13(1):49–55. doi: 10.1007/BF02918224. [DOI] [PubMed] [Google Scholar]
  19. Oldenburg H. S., Pruitt J. H., Lazarus D. D., Rogy M. A., Chizzonite R., Lowry S. F., Moldawer L. L. Interleukin 1 binding to its type I, but not type II receptor, modulates the in vivo acute phase response. Cytokine. 1995 Aug;7(6):510–516. doi: 10.1006/cyto.1995.0069. [DOI] [PubMed] [Google Scholar]
  20. Saijo Shinobu, Asano Masahide, Horai Reiko, Yamamoto Hiroaki, Iwakura Yoichiro. Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells. Arthritis Rheum. 2002 Feb;46(2):533–544. doi: 10.1002/art.10172. [DOI] [PubMed] [Google Scholar]
  21. Satoh H., Chizzonite R., Ostrowski C., Ni-Wu G., Kim H., Fayer B., Mae N., Nadeau R., Liberato D. J. Characterization of anti-IL-1 alpha autoantibodies in the sera from healthy humans. Immunopharmacology. 1994 Mar-Apr;27(2):107–118. doi: 10.1016/0162-3109(94)90045-0. [DOI] [PubMed] [Google Scholar]
  22. Slack J., McMahan C. J., Waugh S., Schooley K., Spriggs M. K., Sims J. E., Dower S. K. Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors. J Biol Chem. 1993 Feb 5;268(4):2513–2524. [PubMed] [Google Scholar]
  23. Suzuki H., Ayabe T., Kamimura J., Kashiwagi H. Anti-IL-1 alpha autoantibodies in patients with rheumatic diseases and in healthy subjects. Clin Exp Immunol. 1991 Sep;85(3):407–412. doi: 10.1111/j.1365-2249.1991.tb05740.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Svenson M., Bagge Hansen M., Bendtzen K. Distribution and characterization of autoantibodies to interleukin 1 alpha in normal human sera. Scand J Immunol. 1990 Dec;32(6):695–701. doi: 10.1111/j.1365-3083.1990.tb03212.x. [DOI] [PubMed] [Google Scholar]
  25. Svenson M., Hansen M. B., Kayser L., Rasmussen A. K., Reimert C. M., Bendtzen K. Effects of human anti-IL-1 alpha autoantibodies on receptor binding and biological activities of IL-1. Cytokine. 1992 Mar;4(2):125–133. doi: 10.1016/1043-4666(92)90047-u. [DOI] [PubMed] [Google Scholar]
  26. Svenson M., Poulsen L. K., Fomsgaard A., Bendtzen K. IgG autoantibodies against interleukin 1 alpha in sera of normal individuals. Scand J Immunol. 1989 Apr;29(4):489–492. doi: 10.1111/j.1365-3083.1989.tb01149.x. [DOI] [PubMed] [Google Scholar]
  27. van de Loo A. A., Arntz O. J., Bakker A. C., van Lent P. L., Jacobs M. J., van den Berg W. B. Role of interleukin 1 in antigen-induced exacerbations of murine arthritis. Am J Pathol. 1995 Jan;146(1):239–249. [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES